Rose A M, Valdes R
Department of Pathology, University of Louisville School of Medicine, KY 40292.
Clin Chem. 1994 Sep;40(9):1674-85.
Na,K-ATPase (sodium pump; EC 3.6.1.37) is present in the membrane of most eukaryotic cells and controls directly or indirectly many essential cellular functions. Regulation of this enzyme (ion transporter) and its individual isoforms is believed to play a key role in the etiology of some pathological processes. The sodium pump is the only known receptor for the cardiac glycosides. However, endogenous ligands structurally similar to digoxin or ouabain may control the activity of this important molecular complex. Here we review the structure and function of Na,K-ATPase, its expression and distribution in tissues, and its interaction with known ligands such as the cardiac glycosides and other suspected endogenous regulators. Also reviewed are various disorders, including cardiovascular, neurological, renal, and metabolic diseases, purported to involve dysfunction of Na,K-ATPase activity. The escalation in knowledge at the molecular level concerning sodium pump function foreshadows application of this knowledge in the clinical laboratory to identify individuals at risk for Na,K-ATPase-associated diseases.
钠钾-ATP酶(钠泵;EC 3.6.1.37)存在于大多数真核细胞的膜中,直接或间接控制许多重要的细胞功能。这种酶(离子转运体)及其各个亚型的调节被认为在某些病理过程的病因学中起关键作用。钠泵是已知的唯一强心苷受体。然而,结构上类似于地高辛或哇巴因的内源性配体可能控制这种重要分子复合物的活性。在这里,我们综述了钠钾-ATP酶的结构和功能、其在组织中的表达和分布,以及它与已知配体如强心苷和其他疑似内源性调节剂的相互作用。还综述了各种疾病,包括心血管疾病、神经疾病、肾脏疾病和代谢疾病,据称这些疾病涉及钠钾-ATP酶活性的功能障碍。在分子水平上关于钠泵功能的知识不断增加,预示着这一知识在临床实验室中的应用,以识别有钠钾-ATP酶相关疾病风险的个体。